3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[2-[(diMethylaMino)Methyl]-4-Morpholinyl]-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo-

3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[2-[(diMethylaMino)Methyl]-4-Morpholinyl]-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo- Struktur
133762-22-8
CAS-Nr.
133762-22-8
Englisch Name:
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[2-[(diMethylaMino)Methyl]-4-Morpholinyl]-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo-
Synonyma:
1-Cyclopropyl-7-[2-[(dimethylamino)methyl]-4-morpholinyl]-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid;3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[2-[(diMethylaMino)Methyl]-4-Morpholinyl]-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo-
CBNumber:
CB82605762
Summenformel:
C21H26FN3O5
Molgewicht:
419.45
MOL-Datei:
133762-22-8.mol

3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[2-[(diMethylaMino)Methyl]-4-Morpholinyl]-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo- Eigenschaften

Sicherheit

3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[2-[(diMethylaMino)Methyl]-4-Morpholinyl]-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo- Chemische Eigenschaften,Einsatz,Produktion Methoden

3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[2-[(diMethylaMino)Methyl]-4-Morpholinyl]-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[2-[(diMethylaMino)Methyl]-4-Morpholinyl]-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hubei Ipure Biology Co., Ltd
+8613367258412
ada@ipurechemical.com China 10319 58
Nanjing Chemlin Chemical Co., Ltd 025-83697070
info@chemlin.com.cn China 19183 64

  • 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[2-[(diMethylaMino)Methyl]-4-Morpholinyl]-6-fluoro-1,4-dihydro-8-Methoxy-4-oxo-
  • 1-Cyclopropyl-7-[2-[(dimethylamino)methyl]-4-morpholinyl]-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
  • 133762-22-8
Copyright 2019 © ChemicalBook. All rights reserved